Other biomarkers have been developed to increase the specificity of ovarian cancer diagnosis, such as human epididymal protein 4 (HE4), a biomarker that is overexpressed in ovarian cancer [54]. The gene discussed is WFDC2; the disease is ovarian carcinoma.